73 research outputs found
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study
Mineralocorticoid receptor antagonists (MRAs) have been demonstrated to improve outcomes in reduced ejection fraction heart failure (HFrEF) patients. However, MRAs added to conventional treatment may lead to worsening of renal function and hyperkalaemia. We investigated, in a population-based analysis, the long-term effects of MRA treatment in HFrEF patients.Aims
Mineralocorticoid receptor antagonists (MRAs) have been demonstrated to improve outcomes in reduced ejection fraction heart failure (HFrEF) patients. However, MRAs added to conventional treatment may lead to worsening of renal function and hyperkalaemia. We investigated, in a population-based analysis, the long-term effects of MRA treatment in HFrEF patients.
Methods and results
We analysed data of 6046 patients included in the Metabolic Exercise Cardiac Kidney Index score
dataset. Analysis was performed in patients treated (n= 3163) and not treated (n= 2883) with MRA. The study endpoint
was a composite of cardiovascular death, urgent heart transplantation, or left ventricular assist device implantation. Ten years\u2019survival was analysed through Kaplan\u2013Meier, compared by log-rank test and propensity score matching.
At 10 years\u2019follow-up, the MRA-untreated group had a significantly lower number of events than the MRA-treated group (P<0.001). MRA-treated patients had more severe heart failure (higher New York Heart Association class and lower left ventricular ejection fraction, kidney function, and peak VO2). At a propensity-score-matching analysis performed on 1587 patients, MRA-treated and MRA-untreated patients showed similar study endpoint values.
Conclusions
In conclusion, MRA treatment does not affect the composite of cardiovascular death, urgent heart transplanta-
tion or left ventricular assist device implantation in a real-life setting. A meticulous patient follow-up, as performed in trials, is likely needed to match the positive MRA-related benefits observed in clinical trials
Evolving changes in lung interstitial fluid content after acute myocardial infarction: mechanisms and pathophysiological correlates
Exercise ventilation inefficiency and cardiovascular mortality in heart failure: the critical independent prognostic value of the arterial CO2 partial pressure
Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure
Influence of ACE-inhibition on salt-mediated worsening of pulmonary gas exchange in heart failure
In congestive heart failure (CHF), pulmonary gas exchange, as evaluated by carbon monoxide diffusion (DLCO), is impaired. ACE-inhibition improves DLCO. Infusion of saline worsens DLCO, because of upregulated sodium and water transport to the alveolar interstitium, which thickens the alveolar-capillary interface and lengthens the diffusion path for gas exchange. We investigated whether enalapril can readjust the capillary permeability to sodium
Exercise metaboreflex activation and endothelial function impairment in atrial fibrillation
Exercise hyperventilation, dyspnea sensation, and ergoreflex activation in lone atrial fibrillation
Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion
Aspirin–Angiotensin-Converting Enzyme Inhibitor Coadministration and Mortality in Patients With Heart Failure
- …